MedPath

UNIVERSITY OF JOHANNESBURG

🇿🇦South Africa
Ownership
-
Established
2005-01-01
Employees
-
Market Cap
-
Website
http://www.uj.ac.za/

Clinical Trials

17

Active:0
Completed:16

Trial Phases

3 Phases

Phase 2:15
Phase 3:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (17 trials with phase data)• Click on a phase to view related trials

Phase 2
15 (88.2%)
Not Applicable
1 (5.9%)
Phase 3
1 (5.9%)

Evaluation of the Impact of a Personal and Domestic Hygiene Intervention on Lead Exposure in a Community Close to a Mine Dump

Not Applicable
Conditions
Lead Poisoning
Lead Poison Children
First Posted Date
2022-03-03
Last Posted Date
2022-04-11
Lead Sponsor
University of Johannesburg
Target Recruit Count
576
Registration Number
NCT05265572
Locations
🇿🇦

Snake Park, Soweto, Johannesburg, Gauteng, South Africa

The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency

Phase 2
Completed
Conditions
Venous Insufficiency
First Posted Date
2015-07-15
Last Posted Date
2016-05-19
Lead Sponsor
University of Johannesburg
Target Recruit Count
40
Registration Number
NCT02498327
Locations
🇿🇦

University of Johannesburg, Johannesburg, Gauteng, South Africa

Venavine Intensive® in the Treatment of Symptoms Associated With Chronic Venous Insufficiency

Phase 2
Completed
Conditions
Venous Insufficiency
First Posted Date
2015-06-29
Last Posted Date
2016-05-19
Lead Sponsor
University of Johannesburg
Target Recruit Count
40
Registration Number
NCT02483962
Locations
🇿🇦

University of Johannesburg, Johannesburg, Gauteng, South Africa

The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome

Phase 2
Completed
Conditions
Premenstrual Syndrome
First Posted Date
2015-06-25
Last Posted Date
2016-05-19
Lead Sponsor
University of Johannesburg
Target Recruit Count
10
Registration Number
NCT02481973
Locations
🇿🇦

University of Johannesburg, Johannesburg, Gauteng, South Africa

The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea

Phase 2
Completed
Conditions
Dysmenorrhea
First Posted Date
2015-06-10
Last Posted Date
2016-05-19
Lead Sponsor
University of Johannesburg
Target Recruit Count
30
Registration Number
NCT02467543
Locations
🇿🇦

University of Johannesburg, Johannesburg, Gauteng, South Africa

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.